Search research articles
Contact Us
Filters
Showing results (111-120 of 369) with videos related to
Page
of 37
Sort By:
Journal of Neurology
|
July 20, 2004
Basal ganglia involvement of a patient with SCA 17--a new form of autosomal dominant spinocerebellar ataxia
P Günther, A Storch, J Schwarz, et al.
European Journal of Pharmacology
|
April 22, 1996
Effects of the antiparkinsonian drug budipine on central neurotransmitter systems
T Klockgether, U Wüllner, J P Steinbach, et al.
Neurology
|
June 9, 2004
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma
W Wick, J P Steinbach, W M Küker, et al.
Cell Death and Differentiation
|
April 16, 1999
Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice
J P Steinbach, U Müller, M Leist, et al.
Brain Pathology (Zurich, Switzerland)
|
January 5, 2002
CD95-mediated apoptosis of human glioma cells: modulation by epidermal growth factor receptor activity
Joachim P Steinbach, Petra Supra, H-J Su Huang, et al.
Oncoimmunology
|
December 10, 2020
Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition
Hans Urban, Laurent M Willems, Michael W Ronellenfitsch, et al.
International Journal of Oncology
|
September 24, 1999
Characterization of Tu-2449, a glioma cell line derived from a spontaneous tumor in GFAP-v-src-transgenic mice: comparison with established murine glioma cell lines
U Pohl, W Wick, J Weissenberger, et al.
Journal of Neuro-Oncology
|
November 7, 2008
ACNU-based chemotherapy for recurrent glioma in the temozolomide era
Caroline Happold, Patrick Roth, Wolfgang Wick, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 21, 2010
Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma
Johanna Gerstein, Kea Franz, Joachim P Steinbach, et al.
Neuro-Oncology
|
August 9, 2013
Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival
Elke Hattingen, Alina Jurcoane, Keivan Daneshvar, et al.
Page
of 37
Search research articles
Search
Showing results (111-120 of 369) with videos related to
Sort By:
Page
of 37
Journal of Neurology
|
July 20, 2004
Basal ganglia involvement of a patient with SCA 17--a new form of autosomal dominant spinocerebellar ataxia
P Günther, A Storch, J Schwarz, et al.
European Journal of Pharmacology
|
April 22, 1996
Effects of the antiparkinsonian drug budipine on central neurotransmitter systems
T Klockgether, U Wüllner, J P Steinbach, et al.
Neurology
|
June 9, 2004
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma
W Wick, J P Steinbach, W M Küker, et al.
Cell Death and Differentiation
|
April 16, 1999
Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice
J P Steinbach, U Müller, M Leist, et al.
Brain Pathology (Zurich, Switzerland)
|
January 5, 2002
CD95-mediated apoptosis of human glioma cells: modulation by epidermal growth factor receptor activity
Joachim P Steinbach, Petra Supra, H-J Su Huang, et al.
Oncoimmunology
|
December 10, 2020
Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition
Hans Urban, Laurent M Willems, Michael W Ronellenfitsch, et al.
International Journal of Oncology
|
September 24, 1999
Characterization of Tu-2449, a glioma cell line derived from a spontaneous tumor in GFAP-v-src-transgenic mice: comparison with established murine glioma cell lines
U Pohl, W Wick, J Weissenberger, et al.
Journal of Neuro-Oncology
|
November 7, 2008
ACNU-based chemotherapy for recurrent glioma in the temozolomide era
Caroline Happold, Patrick Roth, Wolfgang Wick, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 21, 2010
Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma
Johanna Gerstein, Kea Franz, Joachim P Steinbach, et al.
Neuro-Oncology
|
August 9, 2013
Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival
Elke Hattingen, Alina Jurcoane, Keivan Daneshvar, et al.
Page
of 37